Evidence map›Paper›PMID 36172070›Full record

ArticleEXCLI journal2022

Interventions on soy isoflavone molecules to improve their therapeutic potential for prostate cancer treatment.

Vladimir Ajdžanovic, Branka Šošic-Jurjevic, Vesna Vodnik, Branko Filipovic

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EXCLI journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Vladimir AjdžanovicDepartment of Cytology, Institute for Biological Research "Siniša Stankovic" - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Branka Šošic-JurjevicDepartment of Cytology, Institute for Biological Research "Siniša Stankovic" - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Vesna VodnikDepartment of Radiation Chemistry and Physics "GAMMA", "Vinca" Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Branko FilipovicDepartment of Cytology, Institute for Biological Research "Siniša Stankovic" - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
University of Belgrade · RSInstitute of Physics Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36172070
PMCPMC9489893
OpenAlexW4298087676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.